Price Targets
Integrating the reports:
- Fundamentals (Base): The fundamentals report suggests a fair value range of $135 - $155. At $146, we’re in the upper half of that range.
- News Impact (Downward Pressure): The removal of the oil risk premium is a direct negative repricing event. This supports a move toward the lower end of the fundamental range.
- Sentiment & Technicals (Downward Momentum): The bearish technical structure and oversold conditions suggest a path of least resistance is down. The chip resistance at $149-$152 is a major near-term cap. Key support is at $141.97, then the $135-$138 zone (January consolidation).
Risk-Adjusted Price Scenarios:
- Conservative (Bearish Case): $128 - $135. This assumes a break of $141.97 leads to a full retracement toward the start of the January rally, exacerbated by sustained lower oil prices.
- Baseline (Most Likely): $135 - $145. This assumes the stock finds a footing in the prior consolidation zone ($135-$138), but rallies are capped by the dense overhead supply near $145-$150. The stock oscillates in this lower range as it digests the new oil price environment.
- Optimistic (Bullish Reversal): $155 - $165. This requires a rapid reversal in oil prices or a broader market surge, allowing the stock to reclaim its moving averages and challenge the pre-news breakdown level. Given the current evidence, this is the lowest probability scenario in the near term.
Specific Price Targets & Time Horizons:
- 1-Month Target: $138. Expect continued volatility with a test of the $135-$138 support zone. Any bounce likely fails before $150.
- 3-Month Target: $142. Expect a period of base-building between $135 and $145 as the immediate selling pressure abates, but lacking a catalyst for a significant rally.
- 6-Month Target: $148. This assumes the company’s Q2 earnings demonstrate resilience at lower oil prices, and the market begins to refocus on the long-term growth projects. However, the $150-$155 area will remain stiff resistance.
Final Actionable Targets:
- Sell/Short Trigger Zone: $149 - $152
- Downside Target Zone (Next 1-3 Months): $135 - $138
- Invalidation Level for Bearish Thesis: A daily close above $155.